what is kidney cancer?

Renal cell cancer (also called kidney cancer or renal cell adenocarcinoma) is a disease in which malignant (cancer) cells are found in the lining of tubules (very small tubes) in the kidney. There are 2 kidneys, one on each side of the backbone, above the waist. Tiny tubules in the kidneys filter and clean the blood. They take out waste products and make urine. The urine passes from each kidney through a long tube called a ureter into the bladder. The bladder holds the urine until it passes through the urethra and leaves the body.

latest program

Is Sickle Cell Disease a Genetic Defense Against COVID-19?

Dr. Msaouel answers questions from the Sickle Cell community. If the disease or trait evolved as a defense against Malaria, does the reported effectiveness of anti-malaria drugs like hydroxychloroquine (Plaquenil) mean that sickle cell patients have natural resistance to the novel coronavirus, COVID-19?

 

Kidney Cancer hub

Noted disparities

Renal Medullary Carcinoma affects young African and African Americans predominantly. This rare cancer disproportionately afflicts an underrepresented group because it coincides with sickle cell disease.

 

programs

Screen Shot 2019-12-15 at 10_edited.jpg

Is Sickle Cell Disease a Genetic Defense Against COVID-19?

Dr. Msaouel answers questions from the Sickle Cell community. If the disease or trait evolved as a defense against Malaria, does the reported effectiveness of anti-malaria drugs like hydroxychloroquine (Plaquenil) mean that sickle cell patients have natural resistance to the novel coronavirus, COVID-19?

Screen Shot 2019-12-15 at 10_edited.jpg

What Steps Can Patients Take To Detect Renal Medullary Carcinoma Early?

Dr. Pavlos Msaouel breaks down the steps patients can take to detect Renal Medullary Carcinoma (RMC) early. First, patients must know whether they carry the sickle cell trait or not. Second, if blood is present in the urine, going to see a doctor immediately for further testing. Third, if you are indeed diagnosed with RMC, it’s important to contact physicians who are dedicated to treating this cancer. Lastly, get in touch with patient advocates and communities so you are not alone.

Screen Shot 2019-12-15 at 10_edited.jpg

Are Sickle Cell Disease Patients More Susceptible to Renal Medullary Carcinoma?

Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center discusses whether patients with sickle cell disease or who carry the sickle cell trait may be at increased risk for renal medullary carcinoma (RMC).

Screen Shot 2019-12-15 at 10_edited.jpg

Renal Medullary Carcinoma and COVID-19: Protecting Patients with Advanced Cancers

Dr. Msaouel urges cancer patients to be cautious to avoid infection with COVID-19, especially due to increased impact complications that may occur. Monitor for these signs and symptoms to get in early communication with your oncology team.

Screen Shot 2019-12-15 at 10_edited.jpg

How Can Providers Combat Inequities in the Care of Renal Medullary Carcinoma Patients?

Dr. Msaouel tackles the question of how providers can combat inequities in the care of Renal Medullary Carcinoma (RMC) patients. Patients, especially young African Americans, go undiagnosed because of inadequate awareness and screening of RMC. Providers need to raise more awareness about RMC in the US and globally.

Screen Shot 2019-12-15 at 10_edited.jpg

What is Renal Medullary Carcinoma?

Respected oncologist, Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center, explains what renal medullary carcinoma (RMC) is and what symptoms typically present at diagnosis.

Screen Shot 2019-12-15 at 10_edited.jpg

What Treatment Options Are Available for Patients Diagnosed with Renal Medullary Carcinoma?

Dr. Pavlos Msaouel shares how patients can effectively self -advocate if diagnosed with Renal Medullary Carcinoma (RMC). First, a patient must know that treatment for RMC differs from other kidney cancers, so it is necessary to seek experts familiar with the particulars of RMC. Second, patients should reach out to communities who participate in RMC clinical trials.

Screen Shot 2019-12-15 at 10_edited.jpg

What Health Disparities Exist for Patients with Renal Medullary Carcinoma?

Dr. Pavlos Msaouel discusses disparities that exist for patients with Renal Medullary Carcinoma (RMC). Young African Americans as well as Nigerians on a global scale are underdiagnosed due to lack of resources such as health insurance and research reports.

 
 

News

5/11/20

https://www.cell.com/cancer-cell/fulltext/S1535-6108(20)30164-1

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal

Medullary Carcinoma

 

© 2020 Diverse Health Hub